Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Deneberg

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|July 24, 2009
Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survivalEsbjörn Paul, Esbjörn Paul, Bertil Uggla, et al.
Epigenetics|May 29, 2014
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genesYing Qu, Andreas Lennartsson, Verena I Gaidzik, et al.
Epigenetics|April 2, 2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaStefan Deneberg, Meena Kanduri, Dina Ali, et al.
Acta Haematologica|February 1, 2013
A combination regimen of bortezomib, cyclophosphamide and betamethasone gives quicker, better and more durable response than VAD/CyBet regimens: results from a Swedish retrospective analysisKatarina Uttervall, Johannes Admasie, Evren Alici, et al.
Blood Advances|March 24, 2020
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based settingGunnar Juliusson, Martin Jädersten, Stefan Deneberg, et al.
European Journal of Haematology|February 3, 2017
Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registryVladimir Lj Lazarevic, Aldana Rosso, Gunnar Juliusson, et al.
European Journal of Haematology|July 24, 2025
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML-A Population-Based StudyMarkus Liew-Littorin, Linn Deleskog-Spångberg, Stefan Deneberg, et al.
Blood|October 1, 2011
Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marksStefan Deneberg, Philippe Guardiola, Andreas Lennartsson, et al.
Leukemia & Lymphoma|March 15, 2021
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based studyAldana Rosso, Gunnar Juliusson, Fryderyk Lorenz, et al.
Genes, Chromosomes & Cancer|January 12, 2021
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based studyChristina Orsmark-Pietras, Niklas Landberg, Fryderyk Lorenz, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|July 24, 2009
Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survivalEsbjörn Paul, Esbjörn Paul, Bertil Uggla, et al.
Epigenetics|May 29, 2014
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genesYing Qu, Andreas Lennartsson, Verena I Gaidzik, et al.
Epigenetics|April 2, 2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaStefan Deneberg, Meena Kanduri, Dina Ali, et al.
Acta Haematologica|February 1, 2013
A combination regimen of bortezomib, cyclophosphamide and betamethasone gives quicker, better and more durable response than VAD/CyBet regimens: results from a Swedish retrospective analysisKatarina Uttervall, Johannes Admasie, Evren Alici, et al.
Blood Advances|March 24, 2020
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based settingGunnar Juliusson, Martin Jädersten, Stefan Deneberg, et al.
European Journal of Haematology|February 3, 2017
Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registryVladimir Lj Lazarevic, Aldana Rosso, Gunnar Juliusson, et al.
European Journal of Haematology|July 24, 2025
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML-A Population-Based StudyMarkus Liew-Littorin, Linn Deleskog-Spångberg, Stefan Deneberg, et al.
Blood|October 1, 2011
Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marksStefan Deneberg, Philippe Guardiola, Andreas Lennartsson, et al.
Leukemia & Lymphoma|March 15, 2021
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based studyAldana Rosso, Gunnar Juliusson, Fryderyk Lorenz, et al.
Genes, Chromosomes & Cancer|January 12, 2021
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based studyChristina Orsmark-Pietras, Niklas Landberg, Fryderyk Lorenz, et al.
Pageof 3